Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease

Australas J Dermatol. 2023 Sep 12. doi: 10.1111/ajd.14154. Online ahead of print.NO ABSTRACTPMID:37698028 | DOI:10.1111/ajd.14154
Source: The Australasian Journal of Dermatology - Category: Dermatology Authors: Source Type: research